SecBot SecBot
SECBOTREPLAY Home › Report › BMRN

BMRN · BioMarin completed its previously announced acquisition of Alesta…

BIOMARIN PHARMACEUTICAL INC · 8-K filed Sep 1, 2026 at 09:23 ET

At the news

NEUTRALIMPACT 3/10

8-K filed Sep 1, 2026 at 09:23 ET

BioMarin completed its previously announced acquisition of Alesta Therapeutics B.V. on August 31, 2026, making Alesta a wholly owned subsidiary. The filing confirms deal closure but provides no financial terms, pipeline details, or strategic rationale, making it a routine administrative update with limited standalone trading impact.

  • BioMarin completed the acquisition of Alesta Therapeutics B.V. on August 31, 2026.
  • Alesta is now a wholly owned subsidiary of BioMarin.
  • The acquisition was previously announced in an 8-K filed on August 18, 2026.
  • No financial terms, deal value, or strategic details are disclosed in this filing.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access